Trials / Completed
CompletedNCT00387985
Bioequivalence Study in Healthy Volunteers
An Open-label, Single-dose, Randomized, 2-period Crossover, Bioequivalence Study Between the Current Formulation and the New Formulation of MOA-728 Administered Subcutaneously in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Primary: To determine the bioequivalence between the new formulation and the current formulation of the investigational drug, MOA-728.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MOA-728 |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2006-09-01
- Completion
- 2006-09-01
- First posted
- 2006-10-13
- Last updated
- 2019-11-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00387985. Inclusion in this directory is not an endorsement.